Federal Register / Vol. 60, No. 77 / Friday, April 21, 1995 / Notices 19941

NPL Sites

Alabama

Monarch Tile—Florence—(PB95–

159695)

Arkansas

Popile Incorporated—El Dorado—

(PB95–154035)

South 8th Street Landfill (a/k/a West

Memphis Landfill)—West Memphis—

(PB95–154092)

Connecticut

Starr Property—Enfield—(PB95–

154795)

Illinois

Kerr McGee Radiation Areas—West

Chicago—(PB95–154803)

Includes:

Kress Creek

Reed-Keppler Park

Residential Areas

Sewage Treatment Plant

Kentucky

National Electric Coil/Cooper

Industries—Dayhoit (PB95–154639)

Massachusetts

Groveland Wells—Groveland—(PB95–

154084)

New Jersey

Delilah Road—Egg Harbor Township—

(PB95–154076)

Washington

Pacific Sound Resources—Seattle—

(PB95–149241)

Seattle Municipal Landfill/Kent

Highlands—Kent (PB95–154100)

Vancouver Water Station No. 1

Contamination—Vancouver (PB95–

166278)

Non-NPL Petitioned Sites

Louisana

Marine Shale Processors, Incorporated—

Amelia—(PB95–130811)

Dated: April 14, 1995.

Claire V. Broome,

Deputy Administrator, Agency for Toxic

Substances and Disease Registry.

[FR Doc. 95–9878 Filed 4–20–95; 8:45 am]

BILLING CODE 4163–70–P

Centers for Disease Control and

Prevention

[Announcement 531]

Cooperative Agreements for StateBased Birth Defect Surveillance

Demonstration Projects

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1995

funds for a cooperative agreement

program for state-based birth defect

surveillance demonstration projects.

This cooperative agreement will support

the development, implementation, and

evaluation of state-based birth defect

surveillance systems.

The Public Health Service (PHS) is

committed to achieving the health

promotion and disease prevention

objectives of ‘‘Healthy People 2000,’’ a

PHS-led national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority areas of Alcohol

and Other Drugs, Environmental Health,

Maternal and Infant Health, and

Surveillance and Data Systems. (For

ordering a copy of ‘‘Healthy People

2000,’’ see the section ‘‘Where To

Obtain Additional Information.’’)

Authority

This program is authorized under

sections 301, 311 and 317C of the Public

Health Service Act (42 U.S.C. 241, 243,

and 247b–4) as amended.

Smoke-Free Workplace

PHS strongly encourages all grant

recipients to provide a smoke-free

workplace and to promote the nonuse of

all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

All duly constituted State and local

public health agencies that are officially

recognized as such, including State,

local, county, city-county, district, and

territorial health departments are

eligible to apply. Also, universities with

formal agreements for working with

State or local health departments for

carrying out the surveillance and

surveillance-based research are eligible

to apply.

Availability of Funds

Approximately $500,000 is available

in FY 1995 to fund approximately 8 to

12 awards. It is expected that awards

will be made to 4 to 6 States with

operational birth defect surveillance

systems, and to 4 to 6 States with

inactive or no birth defect surveillance

systems. It is expected that the average

award will be $50,000. It is expected

that the awards will begin on or about

September 30, 1995, and will be made

for a 12-month budget period within a

project period of up to 3 years. Funding

estimates may vary and are subject to

change.

These awards may be used for

personnel services, equipment, travel,

and other cost related to project

activities. Project funds may not be used

to supplant State funds available for

birth defect surveillance or birth defect

prevention.

Continuation awards within the

project period will be made on the basis

of satisfactory progress and the

availability of funds.

Purpose

The purpose of this cooperative

agreement is to assist States:

a. To develop and implement pilot

methodologies and approaches which

will improve or expand the State’s

capacity to ascertain cases and generate

timely population-based data of major

birth defects;

b. To engage, and collaborate with

other States and appropriate

organizations in the timely sharing and

analysis of surveillance and

epidemiologic data related to birth

defects and;

c. To evaluate, in a timely fashion, the

effectiveness of surveillance approaches

and progress in the prevention of folic

acid-preventable spina bifida and

anencephaly.

Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under A. (Recipient Activities for States

with inactive or no birth defect

surveillance systems); or B. (Recipient

Activities for States with operational

birth defect surveillance systems); and

CDC will be responsible for the

activities listed under C. (CDC

Activities).

A. Recipient Activities for States with

inactive or no birth defect surveillance

systems:

1. Develop plans for, and begin

implementation of, a pilot state-based

surveillance system which will

ascertain cases and generate populationbased data of major birth defects

occurring in the State.

2. Develop a plan for the sharing and

analysis of surveillance and

epidemiologic data related to birth
19942 Federal Register / Vol. 60, No. 77 / Friday, April 21, 1995 / Notices

defects with other States and

appropriate organizations.

B. Recipient Activities for States with

operational birth defect surveillance

systems:

1. Develop and implement pilot

methodologies and approaches which

will improve or expand the capacity of

an existing state-based surveillance

system to ascertain cases and generate

timely population-based data of major

birth defects occurring in the State.

2. Collaborate with other States and

appropriate organizations in the timely

sharing and analysis of surveillance and

epidemiologic data related to birth

defects.

3. Evaluate, in a timely fashion, the

progress in the prevention of folic acidpreventable spina bifida and

anencephaly in the State.

C. CDC Activities:

1. Provide technical assistance.

2. Assist recipients in designing,

developing, and evaluating pilot and

demonstration components of statebased birth defect surveillance systems.

3. Assist recipients in analyzing

surveillance and epidemiologic data

related to birth defects.

4. Assist recipients in evaluating the

progress in the prevention of folic acidpreventable spina bifida and

anencephaly.

5. Provide a reference point for

sharing regional and national data and

information pertinent to the

surveillance and prevention of birth

defects.

Evaluation Criteria

Applications will be reviewed and

evaluated according to the following

criteria as they relate to the applicant’s

response to either A., or B., in the

‘‘Program Requirements.’’

1. Applicant’s Understanding of the

Problem (10%)

The extent to which the applicant has

a clear, concise understanding of the

requirements, objectives, and purpose of

the cooperative agreement. The extent to

which the application reflects an

understanding of the complexities of

birth defect surveillance.

2. Impact on State-Based Birth Defects

Surveillance (65%)

The extent to which the applicant

describes the anticipated level of impact

this cooperative agreement will have on

birth defect surveillance activities in the

State. This description may include

current and proposed:

a. Methods of case ascertainment;

b. Level of coverage of the population;

c. Specific birth defects ascertained;

d. Timeliness of case ascertainment

and reporting;

e. Utility of surveillance data for

epidemiologic studies and;

f. Utility of surveillance data for

evaluating the progress in the

prevention of folic acid-preventable

spina bifida and anencephaly.

3. Organizational and Program

Personnel Capability (20%)

The extent to which the applicant has

the experience, skills, and ability to

implement and evaluate a birth defect

surveillance system. The adequacy of

the present staff and capability to

assemble competent staff to implement

and evaluate a birth defect surveillance

system and a prevention program. The

applicant shall identify, to the extent

possible, all current and potential

personnel who will work on this

cooperative agreement, including

qualifications and specific experience as

it relates to the requirements set forth in

this request.

4. Matching Funds (5%)

The extent to which the applicant

proposes matching funds. Matching

funds may be contributions by the

recipient of at least five percent of

Federal funds awarded under this

program. The applicant should identify

and describe:

a. The amount expended during the

preceding year for birth defect

surveillance activities and birth defect

prevention activities.

These amounts will be used to

establish a baseline for current and

future match amounts and;

b. Sources of matching funds for the

project and the estimated amounts from

each.

5. Budget Justification and Adequacy of

Facilities (Not Scored)

The budget will be evaluated for the

extent to which it is reasonable, clearly

justified, and consistent with the

intended use of the cooperative

agreement funds. The applicant shall

describe and indicate the availability of

facilities and equipment necessary to

carry out this project. Proposed

matching funds must be detailed in the

budget.

6. Human Subject Review (not scored)

The applicant must clearly state

whether or not human subjects will be

used in research.

Executive Order 12372

Applications are subject to

Intergovernmental Review of Federal

Programs as governed by Executive

Order (E.O.) 12372. E.O. 12372 sets up

a system for State and local government

review of proposed Federal assistance

applications. Applicants should contact

their State Single Point of Contact

(SPOC) as early as possible to alert them

to the prospective applications and

receive any necessary instructions on

the State process. For proposed projects

serving more than one State, the

applicant is advised to contact the SPOC

for each affected State. A current list of

SPOCs is included in the application

kit. If SPOCs have any State process

recommendations on applications

submitted to CDC, they should send

them to Henry S. Cassell III, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Atlanta, GA

30305. (The receipt date for SPOC

comments will be 60 days after the

application deadline date.) The

Announcement Number and Program

Title should be referenced on the

document. The granting agency does not

guarantee to ‘‘accommodate or explain’’

the State process recommendations it

receives after that date.

Public Health System Reporting

Requirement

This program is subject to the Public

Health System Reporting Requirements.

Under these requirements, all

community-based nongovernmental

applicants must prepare and submit the

items identified below to the head of the

appropriate State and/or local health

department agency(s) in the program

area(s) that may be impacted by the

proposed project no later than the

receipt date of the Federal Application.

The appropriate State and/or local

health agency is determined by the

applicant. The following information

must be provided:

A. A copy of the face page of the

application (SF 424).

B. A summary of the project that

should be titled ‘‘Public Health System

Impact Statement’’ (PHSIS), not exceed

one page, and include the following:

1. A description of the population to

be served;

2. A summary of the services to be

provided; and

3. A description of the coordination

plans with the appropriate State and/or

local health agencies.

If the State and/or local health official

should desire a copy of the entire

application, it may be obtained from the

State Single Point of Contact (SPOC) or

directly from the applicant.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance number is 93.283.
Federal Register / Vol. 60, No. 77 / Friday, April 21, 1995 / Notices 19943

Other Requirements

Paperwork Reduction Act

Projects that involve the collection of

information from ten or more

individuals and funded by the

cooperative agreement will be subject to

review by the Office of Management and

Budget (OMB) under the Paperwork

Reduction Act.

Human Subjects

If the proposed project involves

research on human subjects, the

applicant must comply with the

Department of Health and Human

Services Regulations, 45 CFR Part 46,

regarding the protection of human

subjects. Assurance must be provided to

demonstrate that the project will be

subject to initial and continuing review

by an appropriate institutional review

committee. The applicant will be

responsible for providing assurance in

accordance with the appropriate

guidelines and form provided in the

application kit.

Application Submission and Deadline

The original and two copies of the

application PHS Form 5161–1 (OMB

Number 0937–0189) must be submitted

to Henry S. Cassell III, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, GA 30305, on or

before June 20, 1995.

1. Deadline: Applications shall be

considered as meeting the deadline if

they are either:

A. Received on or before the deadline

date; or

B. Sent on or before the deadline date

and received in time for submission to

the objective review group. (Applicants

must request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or U.S. Postal Service. Private metered

postmarks will not be acceptable as

proof of timely mailing.)

2. Late Applications: Applications

which do not meet the criteria in 1.A.

or 1.B., above are considered late

applications. Late applications will not

be considered in the current

competition and will be returned to the

applicant.

Where To Obtain Additional

Information

To receive additional written

information call (404) 332–4561. You

will be asked to leave your name,

address, and phone number and will

need to refer to Announcement 531.

You will receive a complete program

description, information on application

procedures, and application forms.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from

Adrienne S. Brown, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 300, Mailstop E–13, Atlanta, GA

30305, telephone (404) 842–6630.

Programmatic technical assistance may

be obtained from Larry D. Edmonds or

David Montanez, State Services, Birth

Defects and Genetic Diseases Branch,

Division of Birth Defects and

Developmental Disabilities, National

Center for Environmental Health,

Centers for Disease Control and

Prevention (CDC), 4770 Buford Highway

NE., Mailstop F–45, Atlanta, GA 30341–

3724, telephone (404) 488–7170.

Please refer to Announcement 531

when requesting information and

submitting an application.

Potential applicants may obtain a

copy of ‘‘Healthy People 2000’’ (Full

Report, Stock No. 017–001–00474–0) or

‘‘Healthy People 2000’’ (Summary

Report, Stock No. 017–001–00473–1)

referenced in the ‘‘Introduction’’

through the Superintendent of

Documents, Government Printing

Office, Washington, DC 20402–9325,

telephone (202) 512–1800.

Dated: April 14, 1995.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 95–9880 Filed 4–20–95; 8:45 am]

BILLING CODE 4163–18–P

[Announcement 523]

Innovations in Syphilis Prevention in

the United States: Reconsidering the

Epidemiology and Involving

Communities

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1995

funds for cooperative agreements to

conduct research toward substantially

reducing syphilis in the United States,

especially in the southeastern United

States, the region with the highest

syphilis rates. Syphilis is linked to

substantial mortality and morbidity

through congenital syphilis, and

through its ecologic relationship with

and cofactor role in HIV transmission.

Therefore, effective, innovative,

community-based approaches to

syphilis prevention may have an

important multiplier effect on HIV

prevention and adult and infant health

in the communities where syphilis is

most prevalent.

The Public Health Service (PHS) is

committed to achieving the health

promotion and disease prevention

objectives of Healthy People 2000, a

PHS-led national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority area of Sexually

Transmitted Diseases. (To order a copy

of ‘‘Healthy People 2000,’’ see the

section ‘‘Where to Obtain Additional

Information.’’)

Authority

These cooperative agreements are

authorized under Section 318(b) of the

Public Health Service Act (42 U.S.C.

247c(b)) as amended. Applicable

program regulations are found in part 51

(b), subparts A and F of title 42, Code

of Federal Regulations.

Smoke-Free Workplace

The PHS strongly encourages all grant

recipients to provide a smoke-free

workplace and to promote the non-use

of all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive Federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

Applications may be submitted by

public and private, nonprofit and forprofit organizations and governments

and their agencies. Universities,

colleges, research institutions, hospitals,

other public and private organizations,

State and local governments or their

bona fide agents, federally recognized

Indian tribal governments, Indian tribes

or Indian tribal organizations, and

small, minority- or women-owned

businesses are eligible to apply.

Applicants must, however, document

collaboration with each of the following

entities:

1. At least one non-profit, public or

private research institution (e.g.,

university, college, hospital, laboratory);

2. A public health agency in State or

local government; and

3. At least one community-based

organization (CBO) or other institution

or agency with a track record for

working with communities affected by

syphilis in the project area. The CBO

does not need to have a record of

working on the problem of sexually

transmitted diseases, only to have